CapsoVision, Inc (CV) stock
CVNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30733% above fair value
$6.65+0.18 (+2.78%)
Close on Nov 17, 2026Market cap $332.81MP/E –Yield –
CapsoVision price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
CapsoVision's price to book ratio was 23.8× on Nov 11, 2026, against 12.8× a year earlier.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 23.8× | −0.6 |
| 2025 | Dec 31, 2025 | 24.5× | – |
See a number that looks wrong?